The effect of risk factors on surgical and oncological results in high-risk prostate cancer: A multicentre study of the urooncology society, Turkey

被引:1
作者
Izol, Volkan [1 ]
Akdogan, Nebil [1 ]
Ozen, Haluk [2 ]
Akdogan, Bulent [2 ]
Kural, Ali Riza [3 ]
Tuna, Mustafa Bilal [3 ]
Sozen, Sinan [4 ]
Turkeri, Levent [5 ]
Tansug, Mustafa Zuhtu [1 ]
机构
[1] Cukurova Univ, Fac Med, Dept Urol, TR-01330 Adana, Turkey
[2] Hacettepe Univ, Fac Med, Dept Urol, Ankara, Turkey
[3] Acibadem Univ, Acibadem Maslak Hosp, Dept Urol, Istanbul, Turkey
[4] Gazi Univ, Fac Med, Dept Urol, Ankara, Turkey
[5] Acibadem Univ, Altunizade Hosp, Dept Urol, Istanbul, Turkey
关键词
RADICAL PROSTATECTOMY; SURVIVAL; MORTALITY; THERAPY; OUTCOMES; IMPACT; MEN;
D O I
10.1111/ijcp.14281
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose To evaluate the effect of risk factors and selected surgical methods on operative and oncological results of patients undergoing radical prostatectomy (RP) with high-risk prostate cancer (HRPC). Methods Retrospective analysis of patients who underwent RP for HRPC from 13 urology centres between 1990 and 2019 was performed. Groups were created according to the risk factors of D'Amico classification. Patients with one risk factor were included in group 1 where group 2 consisted of patients with two or three risk factors. Results A total of 1519 patients were included in this study and 1073 (70.6%) patients were assigned to group 1 and 446 (29.4%) patients to group 2. Overall (biochemical and/or clinical and/or radiological) progression rate was 12.4% in group 1 and 26.5% in group 2 (P = .001). Surgical procedure was open RP in 844 (55.6%) patients and minimally invasive RP in 675 (44.4%) patients (laparoscopic and robot-assisted RP in 230 (15.1%) and 445 (29.3%) patients, respectively). Progression rates were similar in different types of operations (P = .22). Progression rate was not significantly different in patients who either underwent pelvic lymph node dissection (PLND) or not in each respective group. Conclusion RP alone is an effective treatment in the majority of patients with HRPC and PLND did not affect the progression rates after RP. According to the number of pre-operative high-risk features, as the number of risk factors increases, there is a need for additional treatment.
引用
收藏
页数:7
相关论文
共 50 条
  • [31] Survival Differences in High-Risk Prostate Cancer by Age
    Garcia-Fuentes, Clara
    Guijarro, Ana
    Hernandez, Virginia
    Gonzalo-Balbas, Alvaro
    Jimenez-Alcaide, Estibaliz
    de la Pena, Enrique
    Perez-Fernandez, Elia
    Llorente, Carlos
    UROLOGY JOURNAL, 2023, 20 (04) : 215 - 221
  • [32] Laparoscopic radical prostatectomy for high-risk prostate cancer
    Di Benedetto, Antonina
    Soares, Ricardo
    Dovey, Zach
    Bott, Simon
    McGregor, Roy G.
    Eden, Christopher G.
    BJU INTERNATIONAL, 2015, 115 (05) : 780 - 786
  • [33] Stratification of High-risk Prostate Cancer into Prognostic Categories: A European Multi-institutional Study
    Joniau, Steven
    Briganti, Alberto
    Gontero, Paolo
    Gandaglia, Giorgio
    Tosco, Lorenzo
    Fieuws, Steffen
    Tombal, Bertrand
    Marchioro, Giansilvio
    Walz, Jochen
    Kneitz, Burkhard
    Bader, Pia
    Frohneberg, Detlef
    Tizzani, Alessandro
    Graefen, Markus
    van Cangh, Paul
    Karnes, R. Jeffrey
    Montorsi, Francesco
    Van Poppel, Hein
    Spahn, Martin
    EUROPEAN UROLOGY, 2015, 67 (01) : 157 - 164
  • [34] Individual and joint effects of metformin and statins on mortality among patients with high-risk prostate cancer
    Tan, Xiang-Lin
    E, Jian-Yu
    Lin, Yong
    Rebbeck, Timothy R.
    Lu, Shou-En
    Shang, Mingyi
    Kelly, William K.
    D'Amico, Anthony
    Stein, Mark N.
    Zhang, Lanjing
    Jang, Thomas L.
    Kim, Isaac Yi
    Demissie, Kitaw
    Ferrari, Anna
    Lu-Yao, Grace
    CANCER MEDICINE, 2020, 9 (07): : 2379 - 2389
  • [35] Prostate cancer death is unlikely in high-risk patients following quality permanent interstitial brachytherapy
    Merrick, Gregory S.
    Butler, Wayne M.
    Galbreath, Robert W.
    Lief, Jonathan
    Bittner, Nathan
    Wallner, Kent E.
    Adamovich, Edward
    BJU INTERNATIONAL, 2011, 107 (02) : 226 - 232
  • [36] Very High-Risk Localized Prostate Cancer: Outcomes Following Definitive Radiation
    Narang, Amol K.
    Gergis, Carol
    Robertson, Scott P.
    He, Pei
    Ram, Ashwin N.
    McNutt, Todd R.
    Griffith, Emily
    DeWeese, Theodore A.
    Honig, Stephanie
    Singh, Harleen
    Song, Danny Y.
    Tran, Phuoc T.
    DeWeese, Theodore L.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 94 (02): : 254 - 262
  • [37] Defining and Treating High-Risk Prostate Cancer: Can We Do Better?
    Gerber, Leah
    Banez, Lionel L.
    Freedland, Stephen J.
    EUROPEAN UROLOGY, 2010, 58 (01) : 8 - 9
  • [38] Perioperative and oncological outcomes of radical prostatectomy for high-risk prostate cancer in the UK: an analysis of surgeon-reported data
    Aning, Jonathan J.
    Reilly, Gavin S.
    Fowler, Sarah
    Challacombe, Ben
    McGrath, John S.
    Sooriakumaran, Prasanna
    BJU INTERNATIONAL, 2019, 124 (03) : 441 - 448
  • [39] Optimal Treatment for High-Risk Prostate Cancer
    Ong, Wee Loon
    Koh, Tze Lui
    Millar, Jeremy
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2018, 320 (04): : 404 - 405
  • [40] Radical prostatectomy for high-risk prostate cancer: Biochemical outcome
    Kawamorita, Naoki
    Saito, Seiichi
    Ishidoya, Shigeto
    Ito, Akihiro
    Saito, Hideo
    Kato, Masanori
    Arai, Yoichi
    INTERNATIONAL JOURNAL OF UROLOGY, 2009, 16 (09) : 733 - 738